Ismini Kloukina

792 citations
19 papers · 572 indexed · h-index 12
Topics
Parkinson's Disease Mechanisms and Treatments (5 papers)Skin and Cellular Biology Research (3 papers)Nuclear Structure and Function (3 papers)
Partner nations
GreeceGermanyDenmark

In The Last Decade

Ismini Kloukina

18 papers receiving 565 citations

Peers

Ismini Kloukina
Comparison fields: 5 of 77
  • Molecular Biology 272
  • Neurology 148
  • Cell Biology 112
  • Epidemiology 96
  • Cellular and Molecular Neuroscience 88
Replace Sou Sugitani with:
Sou Sugitani Japan
P. Anthony Otero United States
Alexandra I. Rosa Portugal
Zhengxin Ying China
Maohong Cao China
Crystal Pacut United States
Karin Kappes‐Horn Germany
Saera Song United States
Michiel Krols Belgium
Uttam Ojha South Korea
Ismini Kloukina relative to Sou Sugitani Japan Sou Sugitani's profile →
Citations per field
00.5×4.4×
Sou Sugitani · 1×
Citations per year

Countries citing papers authored by Ismini Kloukina

Since Specialization
Citations

This map shows the geographic impact of Ismini Kloukina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ismini Kloukina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ismini Kloukina more than expected).

Fields of papers citing papers by Ismini Kloukina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ismini Kloukina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ismini Kloukina. The network helps show where Ismini Kloukina may publish in the future.

Co-authorship network of co-authors of Ismini Kloukina

This figure shows the co-authorship network connecting the top 25 collaborators of Ismini Kloukina. A scholar is included among the top collaborators of Ismini Kloukina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ismini Kloukina. Ismini Kloukina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 12
3 15
4 9
5 5
6 3
7 4
8 111
9 8
10 16
11 9
12 51
13 32
14 21
15 35
16 60
17 67
18 94
19 20

About Ismini Kloukina

Ismini Kloukina is a scholar working on Neurology, Neurology and Cell Biology, having authored 19 papers that have together received 572 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Skin and Cellular Biology Research (3 papers) and Nuclear Structure and Function (3 papers). The work is most often cited by research in Neurology (148 citations), Neurology (66 citations) and Cell Biology (112 citations). Ismini Kloukina has collaborated with scholars based in Greece, Germany and Denmark. Frequent co-authors include Maria Xilouri, Leonidas Stefanis, Yassemi Capetanaki, Oeystein Roed Brekk, Alexia Polissidis, Constantinos H. Davos, Aimilia Varela, Manousos Makridakis, Mary Tsikitis and George A. Garinis. Their work appears in journals such as Brain, Cell Metabolism and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026